Rankings
▼
Calendar
VTRS Q1 2017 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena
VTRS
Viatris Inc.
$16B
Q1 2017 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$2.7B
+24.1% YoY
Gross Profit
$1.1B
39.9% margin
Operating Income
$228M
8.4% margin
Net Income
$66M
2.4% margin
EPS (Diluted)
$0.12
QoQ Revenue Growth
-16.8%
Cash Flow
Operating Cash Flow
$453M
Free Cash Flow
$395M
Stock-Based Comp.
$23M
Balance Sheet
Total Assets
$34.3B
Total Liabilities
$22.6B
Stockholders' Equity
$11.7B
Cash & Equivalents
$724M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2.7B
$2.2B
+24.1%
Gross Profit
$1.1B
$907M
+19.6%
Operating Income
$228M
$106M
+115.6%
Net Income
$66M
$14M
+377.7%
← FY 2017
All Quarters
Q2 2017 →